BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3631688)

  • 41. Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2).
    Voigt H; Merant C; Wienhold D; Braun A; Hutet E; Le Potier MF; Saalmüller A; Pfaff E; Büttner M
    Vaccine; 2007 Aug; 25(31):5915-26. PubMed ID: 17600594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coagulation changes in African swine fever virus infection.
    Edwards JF; Dodds WJ; Slauson DO
    Am J Vet Res; 1984 Nov; 45(11):2414-20. PubMed ID: 6441489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The growth of virulent African swine fever virus in pig monocytes and macrophages.
    Wardley RC; Wilkinson PJ
    J Gen Virol; 1978 Jan; 38(1):183-6. PubMed ID: 340610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Passively transferred African swine fever virus antibodies protect swine against lethal infection.
    Onisk DV; Borca MV; Kutish G; Kramer E; Irusta P; Rock DL
    Virology; 1994 Jan; 198(1):350-4. PubMed ID: 8259670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Epidemiological characterization of a pestivirus isolate from a viremic pig out of a mixed pig-cattle herd].
    Frey HR; Röder B; Depner K; Liess B
    Dtsch Tierarztl Wochenschr; 1995 May; 102(5):181-3. PubMed ID: 8593767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs.
    Eblé PL; de Bruin MG; Bouma A; van Hemert-Kluitenberg F; Dekker A
    Vaccine; 2006 Feb; 24(9):1274-81. PubMed ID: 16289709
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
    Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
    Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus.
    Van Reeth K; Braeckmans D; Cox E; Van Borm S; van den Berg T; Goddeeris B; De Vleeschauwer A
    Vaccine; 2009 Oct; 27(45):6330-9. PubMed ID: 19840669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.
    Gupta M; Mahanty S; Bray M; Ahmed R; Rollin PE
    J Virol; 2001 May; 75(10):4649-54. PubMed ID: 11312335
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Leukocyte-dependent platelet vasoactive amine release and immune complex deposition in African swine fever.
    Slauson DO; Sanchez-Vizcaino JM
    Vet Pathol; 1981 Nov; 18(6):813-26. PubMed ID: 6170156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. African swine fever. II. Functional disturbances of thrombocytes in pigs infected with virulent haemadsorbing and non-haemadsorbing virus isolates.
    Neser JA; Kotzé C
    Onderstepoort J Vet Res; 1987 Jun; 54(2):147-55. PubMed ID: 3627730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Flow cytometric analysis of African swine fever virus-induced plasma membrane proteins and their humoral immune response in infected pigs.
    Alcaraz C; Alvarez A; Escribano JM
    Virology; 1992 Jul; 189(1):266-73. PubMed ID: 1376539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. African swine fever in the Americas.
    Reichard RE
    Proc Annu Meet U S Anim Health Assoc; 1978; (82):226-31. PubMed ID: 287092
    [No Abstract]   [Full Text] [Related]  

  • 54. Immune serum increases arenavirus replication in monocytes.
    Lewis RM; Cosgriff TM; Griffin BY; Rhoderick J; Jahrling PB
    J Gen Virol; 1988 Jul; 69 ( Pt 7)():1735-9. PubMed ID: 3292697
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Dynamics of changes in the composition of leukocyte population of peripheral blood during the African swine fever].
    Karalova EM; Arzumanian GA; Zakarian OS; Voskanian GE; Sarkisian KhV; Karalian ZA
    Vopr Virusol; 2012; 57(4):27-31. PubMed ID: 23012981
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The results of international comparative testing of reagents to swine serum protein allotypes conducted in 1987-1988].
    Ermolaev VI; Mirtskhulava EG; Mitichashvili RS; Adeishvili TS; Savina MA; Baranov OK
    Genetika; 1990 May; 26(5):956-7. PubMed ID: 2397888
    [TBL] [Abstract][Full Text] [Related]  

  • 57. African Swine Fever-A Call to Action.
    Higgs S
    Vector Borne Zoonotic Dis; 2018 Oct; 18(10):509-510. PubMed ID: 30222512
    [No Abstract]   [Full Text] [Related]  

  • 58. Electron microscope observations of African swine fever virus in tissue culture cells.
    Breese SS; DeBoer CJ
    Virology; 1966 Mar; 28(3):420-8. PubMed ID: 18611474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PROTECTIVE EFFECT OF SEPARATE INOCULATION OF SPOTTED FEVER VIRUS AND IMMUNE SERUM BY INTRADERMAL ROUTE.
    Anigstein L; Bader MN; Young G
    Science; 1943 Sep; 98(2543):285-6. PubMed ID: 17811500
    [No Abstract]   [Full Text] [Related]  

  • 60. DISSOCIATION OF NEUTRAL VACCINE VIRUS-IMMUNE SERUM MIXTURES.
    Long PH; Olitsky PK
    Science; 1929 Jan; 69(1777):72. PubMed ID: 17730719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.